AMRA Medical
↗Linköping, Sweden
AMRA Medical is a health informatics and digital health company that has developed a global standard in body composition analysis. The company transforms rapid, 6-minute whole-body MRI scans into precise, 3D-volumetric fat and muscle biomarkers. By utilizing artificial intelligence and a massive reference database, AMRA provides highly accurate measurements of visceral adipose tissue, subcutaneous fat, and individual muscle volumes, which are used to improve patient stratification and endpoint selection in clinical trials.
Originally a spin-off from Linköping University, AMRA supports pharmaceutical companies, research institutions, and clinicians in the fields of metabolic disease (MASH/NASH, Diabetes), musculoskeletal disorders (Sarcopenia, FSHD), and cardiovascular health. Their technology is designed to move beyond simple BMI measurements toward a more personalized 'Body Composition Profile' (BCP) that can predict and prevent chronic diseases.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Medical Imaging & Body Composition Analysis
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2010
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$26.8M
Investors:Pfizer Ventures, Novo Nordisk (Novo Seeds), Industrifonden, Kreos Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:FDA Cleared / CE Marked
Modalities:MRI-based Biomarkers, AI-driven Image Analysis, SaaS
Active Trials:12
Trial Phases:Phase 1: 2 | Phase 2: 5 | Phase 3: 4 | Phase 4: 1
FDA Approvals:2
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:AMRA Medical UK, AMRA Medical US
Key Partnerships:Pfizer (Duchenne Muscular Dystrophy research), Eli Lilly (SURPASS-3 trial for Tirzepatide), ContextVision (Liver disease diagnostics collaboration), Prescan (Preventative health in the Netherlands), Human Longevity (Body composition for longevity programs)
COMPETITION
Position:Leader
Competitors:Perspectum, DeepLook, Acer Medical, VoxelCloud
LEADERSHIP
Key Executives:
Olof Dahlqvist Leinhard - CEO & Co-Founder
Klas Themner - CFO & Deputy CEO
Jennifer Linge - Chief Scientific Officer
Scientific Founders:Magnus Borga, Olof Dahlqvist Leinhard
Board Members:Tommy Johansson (Chairman), Barbara Dalton (Pfizer Ventures), Søren Møller (Novo Seeds), Magnus Borga
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AMRA Medical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.